Image 4_Fatty acid synthase inhibition improves hypertension-induced erectile dysfunction by suppressing oxidative stress and NLRP3 inflammasome-dependent pyroptosis through activa... by Jiaochen Luan (9704384)

“…Multi-omics analysis revealed significant enrichment in lipid metabolic pathways, with Fasn identified as a hub gene. …”

Quantitative results on MTDC-UAV dataset. by Dunlu Lu (19964225)

“…This is particularly true in the agricultural field, where there is a multitude of crop types and a complex and variable environment. …”

Table 1_Fatty acid synthase inhibition improves hypertension-induced erectile dysfunction by suppressing oxidative stress and NLRP3 inflammasome-dependent pyroptosis through activa... by Jiaochen Luan (9704384)

“…Multi-omics analysis revealed significant enrichment in lipid metabolic pathways, with Fasn identified as a hub gene. …”

Counting results on WEDU dataset. by Dunlu Lu (19964225)

“…This is particularly true in the agricultural field, where there is a multitude of crop types and a complex and variable environment. …”

Table 2_Fatty acid synthase inhibition improves hypertension-induced erectile dysfunction by suppressing oxidative stress and NLRP3 inflammasome-dependent pyroptosis through activa... by Jiaochen Luan (9704384)

“…Multi-omics analysis revealed significant enrichment in lipid metabolic pathways, with Fasn identified as a hub gene. …”

Supplementary file 2_Exploring dupilumab for asthma: from mechanistic insights to clinical outcomes, safety, and cost-effectiveness.docx by Omar Z. Ameer (8900039)

“…Clinical trials have demonstrated significant reductions in asthma exacerbation rates, improvements in forced expiratory volume in one second (FEV₁), and decreased oral corticosteroid (OCS) dependence in adults and children with moderate-to-severe asthma. …”

Image 2_Fatty acid synthase inhibition improves hypertension-induced erectile dysfunction by suppressing oxidative stress and NLRP3 inflammasome-dependent pyroptosis through activa... by Jiaochen Luan (9704384)

“…Multi-omics analysis revealed significant enrichment in lipid metabolic pathways, with Fasn identified as a hub gene. …”

Example images from four plant datasets. by Dunlu Lu (19964225)

“…This is particularly true in the agricultural field, where there is a multitude of crop types and a complex and variable environment. …”

Table 4_Fatty acid synthase inhibition improves hypertension-induced erectile dysfunction by suppressing oxidative stress and NLRP3 inflammasome-dependent pyroptosis through activa... by Jiaochen Luan (9704384)

“…Multi-omics analysis revealed significant enrichment in lipid metabolic pathways, with Fasn identified as a hub gene. …”

Image 3_Fatty acid synthase inhibition improves hypertension-induced erectile dysfunction by suppressing oxidative stress and NLRP3 inflammasome-dependent pyroptosis through activa... by Jiaochen Luan (9704384)

“…Multi-omics analysis revealed significant enrichment in lipid metabolic pathways, with Fasn identified as a hub gene. …”

Counting results on RFRB dataset. by Dunlu Lu (19964225)

“…This is particularly true in the agricultural field, where there is a multitude of crop types and a complex and variable environment. …”

Detection visualization results on WEDU dataset. by Dunlu Lu (19964225)

“…This is particularly true in the agricultural field, where there is a multitude of crop types and a complex and variable environment. …”

Image 5_Fatty acid synthase inhibition improves hypertension-induced erectile dysfunction by suppressing oxidative stress and NLRP3 inflammasome-dependent pyroptosis through activa... by Jiaochen Luan (9704384)

“…Multi-omics analysis revealed significant enrichment in lipid metabolic pathways, with Fasn identified as a hub gene. …”

Data Sheet 1_Fatty acid synthase inhibition improves hypertension-induced erectile dysfunction by suppressing oxidative stress and NLRP3 inflammasome-dependent pyroptosis through a... by Jiaochen Luan (9704384)

“…Multi-omics analysis revealed significant enrichment in lipid metabolic pathways, with Fasn identified as a hub gene. …”

Table 1_Burden of heart failure attributable to chronic kidney disease in older adults (1990–2021): an analysis from the global burden of disease study.docx by Wenli Liu (400084)

“…Background<p>Heart failure (HF) is a critical global health issue, with chronic kidney disease (CKD) as a significant contributing factor. …”

Table 2_Burden of heart failure attributable to chronic kidney disease in older adults (1990–2021): an analysis from the global burden of disease study.docx by Wenli Liu (400084)

“…Background<p>Heart failure (HF) is a critical global health issue, with chronic kidney disease (CKD) as a significant contributing factor. …”

Table 3_Burden of heart failure attributable to chronic kidney disease in older adults (1990–2021): an analysis from the global burden of disease study.docx by Wenli Liu (400084)

“…Background<p>Heart failure (HF) is a critical global health issue, with chronic kidney disease (CKD) as a significant contributing factor. …”

Table 4_Burden of heart failure attributable to chronic kidney disease in older adults (1990–2021): an analysis from the global burden of disease study.docx by Wenli Liu (400084)

“…Background<p>Heart failure (HF) is a critical global health issue, with chronic kidney disease (CKD) as a significant contributing factor. …”

Heart looping variations in <i>Notch3</i> and <i>Nodal</i> compound mutants. by Tobias Holm Bønnelykke (20968460)

“…(<b>F</b>) Brightfield images of wild type (f1), control <i>Notch3</i> heterozygote (f2) compared to homozygote <i>Nodal</i> mutants with decreased <i>Notch3</i> (f3) at E9.5, in a ventral view. …”

supplementary figure: Osimertinib inhibits the MYLK4-mediated phosphorylation of CDKAL1 to suppress stemness and chemoresistance in rhabdomyosarcoma by Takuto Itano (16830105)

“…(right): Self-renewal capacity of RD and AD-RD cells assessed by a sphere formation assay (n = 4). Statistical significance: ****p < 0.0001. c (top): Immunoblots from in vitro kinase assays treated with hit compounds and with EGFR inhibitors. …”